A century of changes in the mortality and incidence of the principal infections of childhood.
作者信息
Gale A H
出版信息
Arch Dis Child. 1945 Mar;20(101):2-21. doi: 10.1136/adc.20.101.2.
Abstract
摘要
相似文献
1
A century of changes in the mortality and incidence of the principal infections of childhood.
Arch Dis Child. 1945 Mar;20(101):2-21. doi: 10.1136/adc.20.101.2.
2
Variations in the Mortality and Incidence of the Common Infections Diseases of Childhood over a Century.
Proc R Soc Med. 1943 Jan;36(3):97-104. doi: 10.1177/003591574303600301.
3
Trends in incidence, survival and mortality of childhood and adolescent cancer in Austria, 1994-2011.
Cancer Epidemiol. 2016 Jun;42:72-81. doi: 10.1016/j.canep.2016.03.015. Epub 2016 Apr 4.
4
Outcomes for children and adolescents with cancer: challenges for the twenty-first century.
J Clin Oncol. 2010 May 20;28(15):2625-34. doi: 10.1200/JCO.2009.27.0421. Epub 2010 Apr 19.
5
The rise of childhood type 1 diabetes in the 20th century.
Diabetes. 2002 Dec;51(12):3353-61. doi: 10.2337/diabetes.51.12.3353.
6
Trends in childhood cancer incidence and mortality in Catalonia, Spain, 1975-1998.
Eur J Cancer Prev. 2004 Feb;13(1):47-51. doi: 10.1097/00008469-200402000-00008.
7
The dialectics of childhood diarrhea mortality.
Int J Health Serv. 2006;36(3):481-501. doi: 10.2190/EPEY-MQ53-G6P0-RM30.
8
Gastrointestinal disease burden and mortality: A public hospital-based study from 2005 to 2014.
J Gastroenterol Hepatol. 2019 Jan;34(1):124-131. doi: 10.1111/jgh.14377. Epub 2018 Jul 30.
9
Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the United States.
J Natl Cancer Inst. 1999 Jun 16;91(12):1051-8. doi: 10.1093/jnci/91.12.1051.
10
Late Infection-Related Mortality in Asplenic Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study.
J Clin Oncol. 2018 Jun 1;36(16):1571-1578. doi: 10.1200/JCO.2017.76.1643. Epub 2018 Apr 17.
引用本文的文献
1
Epidemiological changes of scarlet fever before, during and after the COVID-19 pandemic in Chongqing, China: a 19-year surveillance and prediction study.
BMC Public Health. 2024 Sep 30;24(1):2674. doi: 10.1186/s12889-024-20116-5.
2
Epidemiological Characteristics and Trends of Scarlet Fever in Zhejiang Province of China: Population-Based Surveillance during 2004-2022.
Can J Infect Dis Med Microbiol. 2024 Jul 14;2024:6257499. doi: 10.1155/2024/6257499. eCollection 2024.
3
Invasive Group A Streptococcal Infections in Europe After the COVID-19 Pandemic.
Dtsch Arztebl Int. 2024 Oct 4;121(20):673-680. doi: 10.3238/arztebl.m2024.0127.
4
Emergent group A evidences a survival strategy during interaction with immune effector cells.
Infect Immun. 2024 Jul 11;92(7):e0015224. doi: 10.1128/iai.00152-24. Epub 2024 Jun 18.
5
The rise and fall of acute rheumatic fever and rheumatic heart disease: a mini review.
Front Cardiovasc Med. 2023 May 23;10:1183606. doi: 10.3389/fcvm.2023.1183606. eCollection 2023.
6
Streptococcal superantigens and the return of scarlet fever.
PLoS Pathog. 2021 Dec 30;17(12):e1010097. doi: 10.1371/journal.ppat.1010097. eCollection 2021 Dec.
7
Exposure to air pollution and scarlet fever resurgence in China: a six-year surveillance study.
Nat Commun. 2020 Aug 25;11(1):4229. doi: 10.1038/s41467-020-17987-8.
8
Rethinking management of neonates at risk of sepsis.
Lancet. 2019 Jul 27;394(10195):279-281. doi: 10.1016/S0140-6736(19)31627-7.
9
Increased Risk for Invasive Group A Streptococcus Disease for Household Contacts of Scarlet Fever Cases, England, 2011-2016.
Emerg Infect Dis. 2019 Mar;25(3):529-537. doi: 10.3201/eid2503.181518. Epub 2019 Mar 17.
10
Resurgence of scarlet fever in China: a 13-year population-based surveillance study.
Lancet Infect Dis. 2018 Aug;18(8):903-912. doi: 10.1016/S1473-3099(18)30231-7. Epub 2018 May 29.
Zotero 插件